• Return to Headlines

Biomarin Pharmac is Among the Companies in the Biotechnology Industry With the Highest EBITDA Growth (BMRN, MDXG, ALXN, CELG, RGEN)

By David Diaz

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks highest with a EBITDA growth of 156.0%. Following is Mimedx Group Inc with a EBITDA growth of 140.6%. Alexion Pharm ranks third highest with a EBITDA growth of 121.4%.

Celgene Corp follows with a EBITDA growth of 116.7%, and Repligen Corp rounds out the top five with a EBITDA growth of 103.7%.

SmarTrend recommended that its subscribers protect gains by selling shares of Celgene Corp on September 11th, 2018 by issuing a Downtrend alert when the shares were trading at $87.66. Since that call, shares of Celgene Corp have fallen 5.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest ebitda growth biomarin pharmac mimedx group inc alexion pharm celgene corp repligen corp

Ticker(s): BMRN MDXG ALXN CELG RGEN